athenahealth (ATHN) Upgraded at BidaskClub

athenahealth (NASDAQ:ATHN) was upgraded by investment analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report issued on Saturday.

Several other analysts also recently commented on the stock. Cantor Fitzgerald reiterated a “hold” rating and issued a $120.00 price target on shares of athenahealth in a research report on Friday, October 27th. SunTrust Banks reiterated a “buy” rating and issued a $156.00 price target on shares of athenahealth in a research report on Wednesday, October 25th. Leerink Swann reduced their price target on shares of athenahealth from $155.00 to $125.00 and set a “market perform” rating for the company in a research report on Monday, October 23rd. Wells Fargo & Company reduced their price target on shares of athenahealth from $190.00 to $155.00 and set an “outperform” rating for the company in a research report on Monday, October 23rd. Finally, Canaccord Genuity reiterated a “hold” rating and issued a $123.00 price target (down previously from $144.00) on shares of athenahealth in a research report on Monday, October 23rd. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and eleven have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $143.22.

athenahealth (NASDAQ ATHN) traded down $0.23 during mid-day trading on Friday, reaching $132.66. 671,978 shares of the company traded hands, compared to its average volume of 339,263. athenahealth has a 1 year low of $90.11 and a 1 year high of $158.66. The stock has a market cap of $5,317.95, a P/E ratio of 112.62, a price-to-earnings-growth ratio of 4.99 and a beta of 1.57. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, beating the consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The firm had revenue of $304.60 million during the quarter, compared to the consensus estimate of $310.52 million. During the same quarter in the prior year, the firm earned $0.60 EPS. athenahealth’s revenue for the quarter was up 10.1% on a year-over-year basis. research analysts anticipate that athenahealth will post 1.2 EPS for the current year.

In other news, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $124.17, for a total transaction of $496,680.00. Following the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at approximately $39,710,435.19. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $130.00, for a total transaction of $104,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 8,483 shares of company stock worth $1,069,532. Corporate insiders own 3.20% of the company’s stock.

Large investors have recently bought and sold shares of the company. Elliott Management Corp acquired a new position in shares of athenahealth during the 2nd quarter worth $52,706,000. UBS Asset Management Americas Inc. grew its stake in shares of athenahealth by 33.2% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock worth $4,292,000 after purchasing an additional 7,605 shares during the period. Scout Investments Inc. grew its stake in shares of athenahealth by 67.2% during the 2nd quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock worth $16,256,000 after purchasing an additional 46,507 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of athenahealth by 1.7% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 72,918 shares of the health services provider’s stock worth $10,249,000 after purchasing an additional 1,222 shares during the period. Finally, Rockefeller Financial Services Inc. grew its stake in shares of athenahealth by 293.2% during the 3rd quarter. Rockefeller Financial Services Inc. now owns 9,110 shares of the health services provider’s stock worth $1,133,000 after purchasing an additional 6,793 shares during the period.

TRADEMARK VIOLATION NOTICE: This news story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/12/02/athenahealth-athn-upgraded-at-bidaskclub.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply